Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AVGO vs MRNA✓SelectedUSD · MRNAAVGO vs MRNA performance historyLatest closeAs of-12.19%11/20
Stock and ETF performance explorer

AVGO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+501.0%
MRNA return
-27.3%
Excess return
+528.3%
Maximum drawdown
-41.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-12.2%-2.2%-10.0%-12.1%
7D-12.3%-12.7%+0.4%-11.7%
30D-9.9%-20.7%+10.8%-9.0%
3M-16.2%+46.3%-62.5%-17.8%
6M-26.9%+305.2%-332.1%-36.8%
YTD-11.6%+561.2%-572.8%-30.3%
1Y-11.6%+772.1%-783.7%-33.6%
3Y+215.8%+147.0%+68.8%+171.4%
All+501.0%-27.3%+528.3%+462.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling